 | • レポートコード：MRC23Q36197 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、61ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のマルチプレックス免疫蛍光アッセイ市場について調査・分析し、世界のマルチプレックス免疫蛍光アッセイ市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（材料、設備、ソフトウェア/サービス）、用途別セグメント分析（学術研究機関、病院、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Fluidigm、Akoya Biosciencesなどが含まれています。世界のマルチプレックス免疫蛍光アッセイ市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、マルチプレックス免疫蛍光アッセイ市場規模を推定する際に考慮しました。本レポートは、マルチプレックス免疫蛍光アッセイの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、マルチプレックス免疫蛍光アッセイに関するビジネス上の意思決定に役立てることを目的としています。 ・マルチプレックス免疫蛍光アッセイ市場の概要 - マルチプレックス免疫蛍光アッセイのタイプ別セグメント - 世界のマルチプレックス免疫蛍光アッセイ市場規模：タイプ別分析（材料、設備、ソフトウェア/サービス） - マルチプレックス免疫蛍光アッセイの用途別セグメント - 世界のマルチプレックス免疫蛍光アッセイ市場規模：用途別分析（学術研究機関、病院、その他） - 世界のマルチプレックス免疫蛍光アッセイ市場規模予測（2018年-2029年） ・マルチプレックス免疫蛍光アッセイ市場の成長トレンド - マルチプレックス免疫蛍光アッセイの地域別市場規模（2018年-2029年） - マルチプレックス免疫蛍光アッセイ市場ダイナミクス - マルチプレックス免疫蛍光アッセイの業界動向 - マルチプレックス免疫蛍光アッセイ市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：材料、設備、ソフトウェア/サービス - 世界のマルチプレックス免疫蛍光アッセイのタイプ別市場規模（2018年-2023年） - 世界のマルチプレックス免疫蛍光アッセイのタイプ別市場規模（2024年-2029年） ・用途別セグメント：学術研究機関、病院、その他 - 世界のマルチプレックス免疫蛍光アッセイの用途別市場規模（2018年-2023年） - 世界のマルチプレックス免疫蛍光アッセイの用途別市場規模（2024年-2029年） ・マルチプレックス免疫蛍光アッセイの地域別市場規模 - 北米のマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - アメリカのマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - ヨーロッパのマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - アジア太平洋のマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - 中国のマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - 日本のマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - 韓国のマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - インドのマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - オーストラリアのマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - 中南米のマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） - 中東・アフリカのマルチプレックス免疫蛍光アッセイ市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Fluidigm、Akoya Biosciences ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Multiplex Immunofluorescence Assay market was valued at US$ 1743.3 million in 2022 and is anticipated to reach US$ 2309.6 million by 2029, witnessing a CAGR of 4.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of multiplex immunofluorescence assay include Fluidigm, Akoya Biosciences. North America is the largest market, with a share about 35%, followed by Asia Pacific and Europe with the share about 30% and 25%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Multiplex Immunofluorescence Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multiplex Immunofluorescence Assay.
The Multiplex Immunofluorescence Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Multiplex Immunofluorescence Assay market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multiplex Immunofluorescence Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Fluidigm
Akoya Biosciences
Segment by Type
Material
Equipment
Software and Service
Segment by Application
Academic and Research Institution
Hospital
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Multiplex Immunofluorescence Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multiplex Immunofluorescence Assay Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Material
1.2.3 Equipment
1.2.4 Software and Service
1.3 Market by Application
1.3.1 Global Multiplex Immunofluorescence Assay Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Academic and Research Institution
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multiplex Immunofluorescence Assay Market Perspective (2018-2029)
2.2 Multiplex Immunofluorescence Assay Growth Trends by Region
2.2.1 Global Multiplex Immunofluorescence Assay Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Multiplex Immunofluorescence Assay Historic Market Size by Region (2018-2023)
2.2.3 Multiplex Immunofluorescence Assay Forecasted Market Size by Region (2024-2029)
2.3 Multiplex Immunofluorescence Assay Market Dynamics
2.3.1 Multiplex Immunofluorescence Assay Industry Trends
2.3.2 Multiplex Immunofluorescence Assay Market Drivers
2.3.3 Multiplex Immunofluorescence Assay Market Challenges
2.3.4 Multiplex Immunofluorescence Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue
3.1.1 Global Top Multiplex Immunofluorescence Assay Players by Revenue (2018-2023)
3.1.2 Global Multiplex Immunofluorescence Assay Revenue Market Share by Players (2018-2023)
3.2 Global Multiplex Immunofluorescence Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Multiplex Immunofluorescence Assay Revenue
3.4 Global Multiplex Immunofluorescence Assay Market Concentration Ratio
3.4.1 Global Multiplex Immunofluorescence Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multiplex Immunofluorescence Assay Revenue in 2022
3.5 Multiplex Immunofluorescence Assay Key Players Head office and Area Served
3.6 Key Players Multiplex Immunofluorescence Assay Product Solution and Service
3.7 Date of Enter into Multiplex Immunofluorescence Assay Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Multiplex Immunofluorescence Assay Breakdown Data by Type
4.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Type (2018-2023)
4.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Type (2024-2029)
5 Multiplex Immunofluorescence Assay Breakdown Data by Application
5.1 Global Multiplex Immunofluorescence Assay Historic Market Size by Application (2018-2023)
5.2 Global Multiplex Immunofluorescence Assay Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Multiplex Immunofluorescence Assay Market Size (2018-2029)
6.2 North America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
6.4 North America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multiplex Immunofluorescence Assay Market Size (2018-2029)
7.2 Europe Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
7.4 Europe Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multiplex Immunofluorescence Assay Market Size (2018-2029)
8.2 Asia-Pacific Multiplex Immunofluorescence Assay Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Region (2018-2023)
8.4 Asia-Pacific Multiplex Immunofluorescence Assay Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multiplex Immunofluorescence Assay Market Size (2018-2029)
9.2 Latin America Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
9.4 Latin America Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multiplex Immunofluorescence Assay Market Size (2018-2029)
10.2 Middle East & Africa Multiplex Immunofluorescence Assay Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2018-2023)
10.4 Middle East & Africa Multiplex Immunofluorescence Assay Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fluidigm
11.1.1 Fluidigm Company Detail
11.1.2 Fluidigm Business Overview
11.1.3 Fluidigm Multiplex Immunofluorescence Assay Introduction
11.1.4 Fluidigm Revenue in Multiplex Immunofluorescence Assay Business (2018-2023)
11.1.5 Fluidigm Recent Development
11.2 Akoya Biosciences
11.2.1 Akoya Biosciences Company Detail
11.2.2 Akoya Biosciences Business Overview
11.2.3 Akoya Biosciences Multiplex Immunofluorescence Assay Introduction
11.2.4 Akoya Biosciences Revenue in Multiplex Immunofluorescence Assay Business (2018-2023)
11.2.5 Akoya Biosciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details